Cytomegalovirus enterocolitis in a patient with dihydropyrimidine dehydrogenase deficiency after capecitabine treatment: A case report

INTRODUCTION: 5-Fluorouracil (5-FU) is widely used for cancer treatment. The reduced activity of dihydropyrimidine dehydrogenase (DPD), the key enzyme in 5-FU inactivation, increases a patient’s risk of developing severe 5-FU related toxicity. However, screening for DPD deficiency is rarely performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Fumiya, Yano, Takuya, Nakahara, Masahiro, Okuda, Hiroshi, Amano, Hironobu, Yonehara, Shuji, Noriyuki, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403100/
https://www.ncbi.nlm.nih.gov/pubmed/30831507
http://dx.doi.org/10.1016/j.ijscr.2019.02.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403100/
https://www.ncbi.nlm.nih.gov/pubmed/30831507
http://dx.doi.org/10.1016/j.ijscr.2019.02.022

Ejemplares similares